Detalhe da pesquisa
1.
Disability outcomes of early cerebellar and brainstem symptoms in multiple sclerosis.
Mult Scler
; 27(5): 755-766, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32538713
2.
Impact of Low Ankle-Brachial Index on the Risk of Recurrent Vascular Events.
Stroke
; 50(4): 853-858, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30852970
3.
Disease-modifying therapies enter the World Health Organization Essential Medicines List: A victory now requiring a roadmap of implementation.
Mult Scler
; 30(1): 3-6, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37850437
4.
Multiple Sclerosis.
Semin Neurol
; 38(2): 212-225, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29791948
5.
Gadolinium effect on thalamus and whole brain tissue segmentation.
Neuroradiology
; 60(11): 1167-1173, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30128599
6.
Catastrophic relapses following initiation of dimethyl fumarate in two patients with neuromyelitis optica spectrum disorder.
Mult Scler
; 23(9): 1297-1300, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28391740
7.
Natalizumab treatment for multiple sclerosis: Middle East and North Africa regional recommendations for patient selection and monitoring.
BMC Neurol
; 14: 27, 2014 Feb 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-24521176
8.
Characteristics of multiple sclerosis in the Middle East with special reference to the applicability of international guidelines to the region.
Int J Neurosci
; 124(9): 635-41, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24228830
9.
Comparative Effectiveness of Natalizumab, Fingolimod, and Injectable Therapies in Pediatric-Onset Multiple Sclerosis: A Registry-Based Study.
Neurology
; 102(7): e208114, 2024 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38447093
10.
Letter to the editor.
Mult Scler
; 24(3): 363, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28747148
11.
Association of Latitude and Exposure to Ultraviolet B Radiation With Severity of Multiple Sclerosis: An International Registry Study.
Neurology
; 98(24): e2401-e2412, 2022 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35410900
12.
Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis.
Neurology
; 99(17): e1926-e1944, 2022 10 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35977837
13.
Will new injection devices for interferon ß-1a s.c. affect treatment adherence in patients with multiple sclerosis? An expert opinion in the Middle East.
Int J Neurosci
; 121(4): 171-5, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21329472
14.
The importance of quality-of-life assessment in the management of patients with multiple sclerosis. Recommendations from the Middle East MS Advisory Group.
Neurosciences (Riyadh)
; 16(2): 109-13, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21427658
15.
MENACTRIMS practice guideline for COVID-19 vaccination in patients with multiple sclerosis.
Mult Scler Relat Disord
; 56: 103225, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34479111
16.
Natalizumab, Fingolimod and Dimethyl Fumarate Use and Pregnancy-Related Relapse and Disability in Women With Multiple Sclerosis.
Neurology
; 2021 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33879599
17.
Adherence to disease-modifying drugs in patients with multiple sclerosis: a consensus statement from the Middle East MS Advisory Group.
Int J Neurosci
; 120(4): 273-9, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20374075
18.
Treatment of multiple sclerosis in special populations: The case of refugees.
Mult Scler J Exp Transl Clin
; 6(1): 2055217319848466, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31976080
19.
Epidemiology and phenotypes of multiple sclerosis in the Middle East North Africa (MENA) region.
Mult Scler J Exp Transl Clin
; 6(1): 2055217319841881, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31984137
20.
Skin warts during fingolimod treatment in patients with multiple sclerosis.
Mult Scler Relat Disord
; 36: 101437, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31606603